No abstract is available. To read the body of this article, please view the Full Text online.
aDepartment of Surgery and Oncology, University of Liverpool, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom
bDepartment of Cancer Research, UK Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, United Kingdom
Corresponding author.
This article was previously published in Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic trypsinogen mutations and pancreatitis. Gastroenterol Clin North Am 2004;33(4):767–87; with permission.
The work undertaken by EUROPAC is funded by grants from the Medical Research Council, North West Cancer Research Fund and Augustus Newnham Foundation, UK; DFG and BMBF of Germany (IZKF Münster grants H3 and D21); Solvay Health Care GmbH, Hanover, Germany; National Institutes of Health grant NIDDK-DK54709 and a Veterans Administration Merit Review grant, USA.
Ambry Genetics (Irvine, California-http://www.ambrygen.com/) has an exclusive license for clinical testings.
